Measuring wall thickness in carotid arteries with MRI may help better determine cardiovascular disease risk assessment, according to research published Oct. 9 in Radiology.

Many breast cancer patients opt for mastectomy believing they won’t require future imaging or biopsy. New research published in the Annals of Surgical Oncology found that is not always the case.

First-of-Its-Kind Program Aims to Help Prevent Sonographer Injuries While Enhancing Patient Care and Reducing Costs.

Charles Apgar has been named executive vice president of the American College of Radiology (ACR)’s Center for Research and Innovation (CRI), according to an Oct. 8 release from the organization.

Synthetic mammogram paired with digital breast tomosynthesis (DBT) achieved similar sensitivity and specificity as full-field digital mammography (FFDM) in identifying microcalcifications during breast screening, according to an Oct. 2 study in Radiology.

Researchers from the Medical University of South Carolina (MUSC) Hollings Cancer Center in Charleston have received a three-year, $1.2 million grant from the U.S. Department of Defense to use molecular imaging tools to test antibody therapies for breast cancer—potentially producing fewer side effects.

NorthStar Medical Radioisotopes in Beloit, Wis. and the Janesville, Wis.-planned SHINE Medical Technologies may receive a portion of the $20 million in federal technology funding bill approved by President Donald Trump to produce molybdenum-99 (Mo-99).

New research suggests patients familiar with electronic quality-of-life (QOL) reporting are more likely to remotely complete a post-appointment questionnaire, according to an interventional radiology study published in the Journal of the American College of Radiology. The findings may improve patient outcome data collection.

A new artificial intelligence (AI) algorithm developed by Canadian researchers can detect evidence of cognitive decline in brain MRI scans, genetics and clinical data, and may predict whether findings will lead to Alzheimer’s disease five years before symptoms appear.

Diffusion-weighted imaging (DWI) could help differentiate between benign and malignant tumors and predict tumor recurrence in breast cancer patients, according to research published Oct. 4 in Academic Radiology. The authors noted that DWI may also serve as a beneficial supplement to contrast-enhanced breast MRI.